Cytosorbents (CTSO) Misses Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
CytoSorbents (CTSO) PT Raised to $16.50 at B.Riley/FBR
August 3, 2018 9:20 AM EDTB.Riley/FBR raised its price target on CytoSorbents (NASDAQ: CTSO) to $16.50 (from $13.00) while maintaining a Buy rating.
... MoreCytoSorbents (CTSO) PT Raised to $18 at Maxim Group
August 3, 2018 7:36 AM EDTMaxim Group raised its price target on CytoSorbents (NASDAQ: CTSO) to $18.00 (from $13.00) while maintaining a Buy rating.
Analsyt Jason McCarthy commented:
Cytosorbents reported another quarter of growth with Cytosorb revenues of $5.24M, up sequentially from $4.4Mthe 24th consecutive quarter of y/y... MoreCytoSorbents (CTSO) PT Raised to $15 at Cowen
August 3, 2018 6:42 AM EDTCowen raised its price target on CytoSorbents (NASDAQ: CTSO) to $15.00 (from $13.00) while maintaining an Outperform rating.
Analyst Josuah Jennings commented, "CTSO again delivered impressive quarterly revenue growth, with product sales of $5.2M, up 72% from last year. Lead product CytoSorb has numerous tailwinds in 2018, including (1) favorable German... More
